AT270868B - Verfahren zur Herstellung von stabilem, hepatitisfreiem Serum - Google Patents

Verfahren zur Herstellung von stabilem, hepatitisfreiem Serum

Info

Publication number
AT270868B
AT270868B AT258467A AT258467A AT270868B AT 270868 B AT270868 B AT 270868B AT 258467 A AT258467 A AT 258467A AT 258467 A AT258467 A AT 258467A AT 270868 B AT270868 B AT 270868B
Authority
AT
Austria
Prior art keywords
hepatitis
stable
production
free serum
serum
Prior art date
Application number
AT258467A
Other languages
German (de)
English (en)
Inventor
Wolfgang Dr Stephan
Original Assignee
Biotest Serum Institut Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE1966B0089704 external-priority patent/DE1617335B2/de
Application filed by Biotest Serum Institut Gmbh filed Critical Biotest Serum Institut Gmbh
Application granted granted Critical
Publication of AT270868B publication Critical patent/AT270868B/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/16—Blood plasma; Blood serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0011—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using physical methods

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Cell Biology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
AT258467A 1966-04-06 1967-03-17 Verfahren zur Herstellung von stabilem, hepatitisfreiem Serum AT270868B (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DEB0086560 1966-04-06
DE1966B0089704 DE1617335B2 (de) 1966-11-05 1966-11-05 Verfahren zur herstellung von lipoproteinfreiem, stabilem und sterilem serum
DEB0091011 1967-02-02

Publications (1)

Publication Number Publication Date
AT270868B true AT270868B (de) 1969-05-12

Family

ID=27209344

Family Applications (1)

Application Number Title Priority Date Filing Date
AT258467A AT270868B (de) 1966-04-06 1967-03-17 Verfahren zur Herstellung von stabilem, hepatitisfreiem Serum

Country Status (8)

Country Link
US (1) US3686395A (ko)
AT (1) AT270868B (ko)
BE (1) BE696020A (ko)
FR (1) FR7395M (ko)
GB (1) GB1115849A (ko)
NL (1) NL6702923A (ko)
SE (1) SE328089B (ko)
SU (1) SU477580A3 (ko)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3822095A (en) * 1972-08-14 1974-07-02 Block Engineering System for differentiating particles
DE2364317C3 (de) * 1973-12-22 1979-10-11 Behringwerke Ag, 3550 Marburg Verfahren zur Isolierung von Choleragen
DK139056B (da) * 1976-04-06 1978-12-11 Nordisk Insulinlab Fremgangsmåde til udvinding af immunoglobulin, der er egnet til intravenøs indgivelse.
US4164495A (en) * 1976-04-06 1979-08-14 Nordisk Insulinlaboratorium Method of recovering immunoglobulin using a polyol and an alkanoic acid
US4136094A (en) * 1977-08-31 1979-01-23 The Regents Of The University Of Minnesota Preparation of intravenous human and animal gamma globulins and isolation of albumin
JPS5446813A (en) * 1977-09-22 1979-04-13 Toyo Soda Mfg Co Ltd Separation of plasmaprotein
DE2837168A1 (de) * 1978-08-25 1980-03-06 Blutspendedienst Dt Rote Kreuz Verfahren zur herstellung einer fuer die intravenoese anwendung geeigneten immunglobulinloesung
US4228154A (en) * 1979-02-26 1980-10-14 Armour Pharmaceutical Company Purification of plasma albumin by ion exchange chromatography
US4251510A (en) * 1979-08-15 1981-02-17 Cutter Laboratories, Inc. Intravenously injectable solution of plasma protein fraction free from bradykinin, kininogen and prekallikrein activators and processes for its production
US4378346A (en) * 1979-08-15 1983-03-29 Tankersley Donald L Intravenously injectable solution of plasma protein fraction free from bradykinin, kininogen and prekallikrein activators and processes for its production
US4473647A (en) * 1981-02-27 1984-09-25 Amf Inc. Tissue culture medium
US4480029A (en) * 1981-04-27 1984-10-30 Baxter Travenol Laboratories, Inc. Biological indicators and their use
US4511473A (en) * 1982-02-09 1985-04-16 Amf Incorporated Fibrous media containing millimicron-sized particulates
US4578150A (en) * 1982-07-23 1986-03-25 Amf Inc. Fibrous media containing millimicron-sized particulates
DE3247150A1 (de) * 1982-12-21 1984-06-28 Biotest-Serum-Institut Gmbh, 6000 Frankfurt Gerinnungsaktive plasmaproteinloesung, verfahren zu ihrer herstellung und ihre verwendung zur behandlung von stoerungen des haemostasesystems
WO1984002916A1 (en) * 1983-01-26 1984-08-02 Amf Inc Tissue culture medium
US4533634A (en) * 1983-01-26 1985-08-06 Amf Inc. Tissue culture medium
US4639513A (en) * 1984-02-02 1987-01-27 Cuno Inc. Intravenously injectable immunoglobulin G (IGG) and method for producing same
ATE59145T1 (de) * 1983-05-02 1991-01-15 Diamond Scient Co Photochemische entkeimungsbehandlung von vollem blut oder blutbestandteilen.
US4764369A (en) * 1983-07-14 1988-08-16 New York Blood Center Inc. Undenatured virus-free biologically active protein derivatives
US4820805A (en) * 1983-07-14 1989-04-11 New York Blood Center, Inc. Undenatured virus-free trialkyl phosphate treated biologically active protein derivatives
DE3330770A1 (de) * 1983-08-26 1985-03-14 Behringwerke Ag, 3550 Marburg Verfahren zur pasteurisierung von humanplasma
US6187572B1 (en) 1990-04-16 2001-02-13 Baxter International Inc. Method of inactivation of viral and bacterial blood contaminants
US5418130A (en) * 1990-04-16 1995-05-23 Cryopharm Corporation Method of inactivation of viral and bacterial blood contaminants
NL9401535A (nl) * 1994-09-21 1996-05-01 Stichting Scheikundig Onderzoe Uit serum bereid eiwitmengsel voor het gebruik als component in media voor het in vitro kweken van dierlijke cellen.
AU2005229674B2 (en) * 2004-11-18 2010-11-04 Kedrion Melville Inc. Low concentration solvent/detergent process of immuneglobulin with pre-treatment

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2469193A (en) * 1942-02-09 1949-05-03 Research Corp Protein fractionation
US3284434A (en) * 1960-08-29 1966-11-08 Univ Kansas State Protein isolation and preparations

Also Published As

Publication number Publication date
FR7395M (ko) 1969-11-03
BE696020A (ko) 1967-09-25
SU477580A3 (ru) 1975-07-15
SE328089B (ko) 1970-09-07
NL6702923A (ko) 1967-10-09
GB1115849A (en) 1968-05-29
US3686395A (en) 1972-08-22

Similar Documents

Publication Publication Date Title
AT270868B (de) Verfahren zur Herstellung von stabilem, hepatitisfreiem Serum
CH478862A (de) Verfahren zur Herstellung von Poly-e-caproamid
CH547816A (de) Verfahren zur herstellung von aminothiophen-derivaten.
CH556355A (de) Verfahren zur herstellung von 5-chromenolaethern.
AT269855B (de) Verfahren zur Herstellung von neuen 5-Nitrofuran- bzw. 5-Nitrothiopen-Derivaten
CH470367A (de) Verfahren zur Herstellung von Sulfonen
CH495348A (de) Verfahren zur Herstellung von a-Oxo-a, B-seco-steroid-B(y)-inen
AT264134B (de) Verfahren zur Herstellung von Poly-N-oxyden
CH555800A (de) Verfahren zur herstellung von naphthylisopropylaminen.
AT266810B (de) Verfahren zur Herstellung von ɛ-Caprolacton
AT275748B (de) Verfahren zur Herstellung von 9β,10α-Steroiden
CH461499A (de) Verfahren zur Herstellung von 5H-Dibenzo-(b,f)-azepin
AT277240B (de) Verfahren zur Herstellung von 6-Styryl-5,6-dihydro-α-pyronen
AT272294B (de) Verfahren zur Herstellung von α,ω-Alkylendiaminen
AT256808B (de) Verfahren zur Herstellung von ɛ-Caprolactam
CH475264A (de) Verfahren zur Herstellung von 2-Arylamino-4,6-dichlor-s-triazinen
CH475208A (de) Verfahren zur Herstellung von Cyanophenolen
AT272295B (de) Verfahren zur Herstellung von α,ω-Alkylendiaminen
CH483388A (de) Verfahren zur Herstellung von Tritylaminen
AT266809B (de) Verfahren zur Herstellung von ɛ-Caprolacton
AT260889B (de) Verfahren zur Herstellung von ɛ-Caprolactam
CH532573A (de) Verfahren zur Herstellung von 4-cis-Cyclohexan-1,2-dicarboximiden
AT280236B (de) Verfahren zur Herstellung von β-Ionen
AT270068B (de) Verfahren zur Herstellung von Anti-Rh-γ-Globulin
CH483415A (de) Verfahren zur Herstellung von 3-Alkoxy-6-cyan-3,5-pregnadienen